Skip Nav Destination
Issues
1 December 2011
-
Cover Image
Cover Image
Trop2, a transmembrane protein reported to be overexpressed in various epithelial tumors and whose function has been elusive, is found to possess an unexpected tumor suppressor role. Trop2 knockout mice develop skin cancers upon exposure to carcinogens in collaboration with loss of the tumor suppressor gene, Arf. Tumors arising in this context are biphasic sarcomatoid carcinomas that possess both E-cadherin-positive squamous and vimentin-positive spindle cell histology. The photomicrograph shows immunofluorescence of a representative tumor possessing both E-cadherin positive (red) and E-cadherin-negative, vimentin-positive (green) cells corresponding to squamous and spindle cell histology respectively (not shown); nuclei are stained blue with 4′,6-diamidino-2-phenylindole. For further details, please see Wang and coworkers on page 1686 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Reviews
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cancer Genes and Genomics
Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells
Yue Liu; Fei Ye; Kazunari Yamada; Jonathan L. Tso; Yibei Zhang; David H. Nguyen; Qinghua Dong; Horacio Soto; Jinny Choe; Anna Dembo; Hayley Wheeler; Ascia Eskin; Ingrid Schmid; William H. Yong; Paul S. Mischel; Timothy F. Cloughesy; Harley I. Kornblum; Stanley F. Nelson; Linda M. Liau; Cho-Lea Tso
Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma
Jianbo Wang; Kaihua Zhang; Dorota Grabowska; Aimin Li; Yiyu Dong; Ryan Day; Peter Humphrey; James Lewis; Raleigh D. Kladney; Jeffrey M. Arbeit; Jason D. Weber; Christine H. Chung; Loren S. Michel
DNA Damage and Cellular Stress Responses
Signaling and Regulation
Reviewers
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.